Taken together, data about IL-36 in RA seem to support the pursuit of its blockade for therapeutic purposes in this disease, Conversely, whether the anti-inflammatory cytokine IL-38 should be considered a new therapeutic option in arthritis or other inflammatory diseases deserves further experiments. This evidence concerns the gene IL1F10 and arthritic joint disease.